These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2193790)

  • 1. [Fibrinolysis therapy using APSAC in acute myocardial infarct].
    Hochrein H
    Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of survival using anistreplase (Eminase)].
    Murray RG
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():37-40. PubMed ID: 2108645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A symposium: Early intervention in the treatment of acute myocardial infarction--clinical profile of Eminase (APSAC). November 12, 1988, Washington, D.C.
    Am J Cardiol; 1989 Jul; 64(2):1A-42A. PubMed ID: 2662736
    [No Abstract]   [Full Text] [Related]  

  • 6. Anistreplase (APSAC): a clinical investigator's update. A symposium. Bermuda, August 1989. Proceedings.
    Clin Cardiol; 1990 Mar; Suppl 5():V1-72. PubMed ID: 2182233
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction.
    Hillis WS; Hornung RS
    Eur Heart J; 1985 Nov; 6(11):909-12. PubMed ID: 3908105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombolytic therapy of acute heart infarct].
    Arnold AE; Simoons ML; Lubsen J
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):335-8. PubMed ID: 2494462
    [No Abstract]   [Full Text] [Related]  

  • 9. Anistreplase for acute coronary thrombosis.
    Med Lett Drugs Ther; 1990 Feb; 32(812):15-6. PubMed ID: 2406552
    [No Abstract]   [Full Text] [Related]  

  • 10. The APSAC interventional mortality study (AIMS) trial: mortality data.
    Julian DG
    Clin Cardiol; 1990 Mar; Suppl 5():V20-1; discussion V27-32. PubMed ID: 2182236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic fibrinolysis following resuscitation or temporary electrostimulation].
    Jäger D; Machraoui A; Melz F; Scholz-Jäger A; Straub H; Barmeyer J
    Dtsch Med Wochenschr; 1990 Jun; 115(26):1009-13. PubMed ID: 2193792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin].
    Cassagnes J; Bassand JP; Machecourt J; Lusson JR; Anguenot T; Borel E; Vacher D; Denis B; Maurat JP; Jallut H
    Arch Mal Coeur Vaiss; 1990 Apr; 83(4):453-60. PubMed ID: 2111665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anistreplase in the treatment of myocardial infarction].
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():1-45. PubMed ID: 2108640
    [No Abstract]   [Full Text] [Related]  

  • 20. AIMS. The design and conduct of a multicentre mortality study comparing placebo and anisoylated plasminogen streptokinase activator complex 30 units intravenously for the treatment of acute myocardial infarction of less than 6 hours duration. UK APSAC Advisory Committee.
    Drugs; 1987; 33 Suppl 3():227-8. PubMed ID: 3315598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.